Css LLC Abb Vie Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.01 Million - $1.15 Million	7,500 Added 37.5%	27,500 $3.69 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $2.27 Million - $2.89 Million	-16,500 Reduced 45.21%	20,000 $3.06 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $857,869 - $1.06 Million	6,500 Added 21.67%	36,500 $5.92 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $3.07 Million - $3.38 Million	30,000 New	30,000 $3.25 Million

3,694

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.